The molecular clock maintains energy constancy by producing circadian oscillations of rate-limiting enzymes involved in tissue metabolism across the day and night 1-3 . During periods of feeding, pancreatic islets secrete insulin to maintain glucose homeostasis, and although rhythmic control of insulin release is recognized to be dysregulated in humans with diabetes 4 , it is not known how the circadian clock may affect this process. Here we show that pancreatic islets possess self-sustained circadian gene and protein oscillations of the transcription factors CLOCK and BMAL1. The phase of oscillation of islet genes involved in growth, glucose metabolism and insulin signalling is delayed in circadian mutant mice, and both Clock 5,6 and Bmal1 7 (also called Arntl) mutants show impaired glucose tolerance, reduced insulin secretion and defects in size and proliferation of pancreatic islets that worsen with age. Clock disruption leads to transcriptome-wide alterations in the expression of islet genes involved in growth, survival and synaptic vesicle assembly. Notably, conditional ablation of the pancreatic clock causes diabetes mellitus due to defective b-cell function at the very latest stage of stimulus-secretion coupling. These results demonstrate a role for the b-cell clock in coordinating insulin secretion with the sleepwake cycle, and reveal that ablation of the pancreatic clock can trigger the onset of diabetes mellitus.
The molecular clock maintains energy constancy by producing circadian oscillations of rate-limiting enzymes involved in tissue metabolism across the day and night [1] [2] [3] . During periods of feeding, pancreatic islets secrete insulin to maintain glucose homeostasis, and although rhythmic control of insulin release is recognized to be dysregulated in humans with diabetes 4 , it is not known how the circadian clock may affect this process. Here we show that pancreatic islets possess self-sustained circadian gene and protein oscillations of the transcription factors CLOCK and BMAL1. The phase of oscillation of islet genes involved in growth, glucose metabolism and insulin signalling is delayed in circadian mutant mice, and both Clock 5,6 and Bmal1 7 (also called Arntl) mutants show impaired glucose tolerance, reduced insulin secretion and defects in size and proliferation of pancreatic islets that worsen with age. Clock disruption leads to transcriptome-wide alterations in the expression of islet genes involved in growth, survival and synaptic vesicle assembly. Notably, conditional ablation of the pancreatic clock causes diabetes mellitus due to defective b-cell function at the very latest stage of stimulus-secretion coupling. These results demonstrate a role for the b-cell clock in coordinating insulin secretion with the sleepwake cycle, and reveal that ablation of the pancreatic clock can trigger the onset of diabetes mellitus.
The circadian clock drives cycles of energy storage and utilization in plants, flies and mammals in anticipation of changes in the external environment imposed by the rising and setting of the Sun 1 . In mammals, the transcription factors CLOCK and BMAL1 drive the central oscillator within the hypothalamus and even in peripheral tissues, yet a major question remains regarding the link between cellular rhythms and organismal homeostasis, including the constancy of energy and fuel utilization cycles 8, 9 . In humans, one of the most pronounced rhythmic aspects of physiology involves the daily variation of glucose tolerance and insulin sensitivity across the 24-h day, and importantly, disruption of circadian oscillation of glucose metabolism is a hallmark of type 2 diabetes 4 . Moreover, there is growing evidence that metabolic and circadian systems are interconnected at the transcriptional level, as genomic analyses have revealed that both neural and peripheral clocks regulate the 24-h periodicity of RNAs that mediate rate-limiting steps in glycolysis, fatty acid oxidation and oxidative phosphorylation, indicating that these processes are primed to occur at the optimal time during glucose and fatty acid utilization cycles 2,10-13 .
Prompted by the hypothesis that the circadian clock exerts effects on metabolism through cellular actions, we sought to dissect the impact of clock function within the pancreatic islet, a principal regulator of glucose homeostasis. We used real-time bioluminescence imaging in isolated pancreatic islets from Per2 Luc knock-in mice (mice expressing a period2-luciferase fusion protein) to determine whether the clock is expressed autonomously within pancreas 14 . Continuous monitoring of light emission from individual islets revealed a self-sustained highamplitude rhythm of PER2-LUC expression with a period length of 23.58 6 0.3 h (Fig. 1a, b and Supplementary Movies 1 and 2), which closely matched that of other peripheral tissues and the suprachiasmatic nucleus ( Fig. 1b) 14, 15 . The oscillation gradually dampened after 3 days, similar to pituitary and liver (Fig. 1b ), and addition of 10 mM forskolin to islets led to immediate re-initiation of robust rhythms ( Fig. 1c ). Bioluminescence from individual islets from Clock D19/D19 mutant mice lacked a circadian rhythm, even after forskolin stimulation ( Fig. 1c ). Quantitative real-time polymerase chain reaction (PCR) showed that Per2 RNA expression was reduced and rhythmicity abolished in islets from Clock D19/D19 mutant mice ( Fig. 1d ). Together, the PER2 protein and mRNA oscillation in wild-type islets, as well as the loss of rhythmicity of Per2 in Clock D19/D19 islets, provide evidence for a self-sustained clock in endocrine pancreas.
Because a major mechanism of circadian regulation involves the cycling of genes involved in cell metabolism and proliferation, we examined 24-h RNA rhythms of essential transcripts involved in insulin secretion and b-cell growth in isolated islets (Supplementary Fig. 1 ). Clock D19/D19 mutant islets showed decreased expression levels of genes downstream of CLOCK and BMAL1 that comprise the core circadian loop, as well as the D-box and ROR feedback loops ( Fig. 1d ). Clock D19/D19 mutant mice also showed decreased levels of expression and/or phase shifts of RNA oscillation of genes involved in insulin signalling (Insr, Irs2, PI3K (also called Pik3r1), Akt2), glucose sensing (Glut2 (Slc2a2), Gck), and islet growth and development (Ccnd1, Gsk3b, Hnf4a, Hnf1a, Pdx1, Neurod1) ( Supplementary Fig. 1 ). The alterations in temporal patterns of gene expression in Clock D19/D19 mutant islets were distinct from those in Clock D19/D19 mutant liver, reflecting partitioning of metabolic functions within these two tissues at different times of day ( Supplementary Figs 1 and 2 and Supplementary Description 1).
To determine whether molecular disruption of the clock in pancreas corresponds with abnormalities in the temporal control of glucose metabolism, we analysed 24-h glucose and insulin profiles in 8-monthold Clock D19/D19 mutant mice and their wild-type littermates during ad libitum feeding. In Clock D19/D19 mutant mice, glucose levels were elevated across the entire light/dark cycle without a rise in insulin levels, whereas insulin rises in wild-type mice during the beginning of the feeding period ( Fig. 2a, b ). Clock D19/D19 mutant mice also displayed significantly elevated fasting glucose levels at both ZT2 and ZT14 (Zeitgeber time) ( Supplementary Fig. 3e , f). Glucose tolerance tests further revealed a 50% reduction in insulin release, corresponding with elevated glucose levels in Clock D19/D19 mutant mice, particularly at the beginning of the dark period ( Fig. 2c, d and Supplementary Description 2). The likelihood that impaired glucose tolerance in Clock D19/D19 mutant mice involves a primary defect in pancreatic function was further supported by the finding that these animals have normal insulin tolerance ( Supplementary Fig. 3c, d) .
For a better understanding of the impact of the circadian gene mutation on pancreatic function, we examined glucose-stimulated insulin secretion (GSIS) in isolated size-matched pancreatic islets from 8-month-old mice. Islets from Clock D19/D19 mice displayed a ,50% reduction in GSIS ( Fig. 3a ) and failed to respond to KCl (Fig. 3b ), indicating a defect in insulin exocytosis. Consistent with a predominant defect in insulin release rather than glucose metabolism, we observed normal calcium flux in response to 12 mM glucose in Clock D19/D19 mutant compared to wild-type islets (Supplementary Fig. 5d , e). Also consistent with defects in exocytosis, islets from Clock D19/D19 mutant mice displayed diminished insulin secretory responses to the cyclase activators forskolin and exendin 4, as well as to 8-bromoadenosine 39,59-cyclic monophosphate (8-bromo-cAMP), localizing the impaired function of Clock D19/D19 mutant islets to a late stage in stimulus-secretion coupling 16 (Fig. 3b ). Finally, in agreement with an exocytic defect as the cause of decreased insulin release in circadian mutant mice, we did not observe a significant difference in either absolute insulin mRNA levels ( Supplementary Fig. 1b ) or in islet insulin content (wild type, 38.2 ng insulin per islet; Clock D19/D19 , 32.9 ng insulin per islet, P 5 0.08). In contrast to 8-month-old Clock D19/D19 mutant mice, we found that fasting and fed glucose levels in 3-month-old Clock D19/D19 mutants were normal and that they had enhanced insulin sensitivity, possibly due to clock disruption at the level of either liver, skeletal muscle or adipose tissue ( Supplementary Fig. 4a-f ). Nonetheless, isolated islets even from young Clock D19/D19 mutant mice displayed impaired GSIS ( Supplementary Fig. 4g ). These observations are consistent with early onset of a primary islet cell defect that only manifests as overt diabetes in .8-month-old Clock D19/D19 mutants, probably due to the gradual onset of insulin resistance during ageing (compare Supplementary Fig. 3c, d and Supplementary Fig. 4e, f) , unmasking the b-cell defect and thereby resulting in age-associated hyperglycaemia and hypoinsulinaemia.
Functional defects in insulin secretion have previously been shown to arise because of impairment of genetic pathways that alter islet proliferation and survival [17] [18] [19] [20] [21] . In this regard, although indirect immunofluorescence revealed normal overall architecture of islets of Clock D19/D19 mice (Fig. 3c ), light microscopy of isolated islets revealed that Clock D19/D19 mutant islets were smaller than those of wild type (Fig. 3d ). Total islet area was also reduced by ,20% in Clock D19/D19 mice based on morphometric analysis of intact pancreata, corresponding with a trend towards decreased total pancreatic insulin content ( Supplementary Fig. 5a, b ). To determine whether the observed decrease in islet size corresponded with decreased islet proliferation, we stained pancreatic sections with the proliferation marker Ki67. Surprisingly, we found a 23% decrease in proliferation in islets from Clock D19/D19 mutant animals ( Fig. 3e ), together with a trend towards increased islet apoptosis ( Supplementary Fig. 5c ). Microarray analysis revealed decreased levels of genes encoding components of E-box, D-box and ROR transcription modules (Per1, Per3, Rev-erba (also called Nr1d1), Tef, Dbp) ( Supplementary  Description 3, Supplementary Fig. 6b and Supplementary Tables 1  and 2 ). Gene Ontogeny enrichment revealed significant alterations in vesicular docking and trafficking factors (including Vamp3 and Stx6) and increases in the cell death factor S100a6 ( Supplementary Fig. 7 and Supplementary Description 4), consistent with reduced function and size of islets from Clock D19/D19 mutant mice.
To determine whether the defects of islet function and size are unique to Clock D19/D19 mice, or instead reflect a generalized role for the core circadian network in islet function, we analysed both GSIS and islet size in Bmal1 2/2 mutant mice 7 . Bmal1 2/2 islets exhibited up to a 60% reduction in insulin secretion compared with littermate controls in response to glucose, KCl, exendin 4, forskolin and 8-bromo-cAMP ( Fig. 3f, g) . Furthermore, there was a twofold reduction in the percentage of large islets in Bmal1 2/2 mice compared with wild-type littermates (Fig. 3d ). The similarity of defects in islets from Clock D19/D19 mutant mice and Bmal1 2/2 mice suggests that multiple core circadian genes have an impact on b-cell function and development.
To evaluate further the contribution of the pancreatic clock to both whole-body glucose metabolism and to islet function, we generated pancreas-specific Bmal1 mutant mice using the promoter of the homeodomain transcription factor PDX1 to drive expression of Cre recombinase 22, 23 (Fig. 4) . We performed immunofluorescent staining to confirm loss of BMAL1 expression specifically within pancreatic islets (Fig. 4a ) and not within brain regions such as the suprachiasmatic nucleus, arcuate nucleus, dorsomedial hypothalamus and paraventricular nucleus ( Fig. 4b and Supplementary Fig. 8 ). Quantitative realtime PCR analysis of key circadian genes in islet and liver from PdxCre Bmal1 flx/flx (where coding exon 4 of Bmal1 is flanked by loxP sites) and control mice revealed islet-specific alterations in gene expression profiles ( Fig. 4c and Supplementary Description 5) , further confirming the specificity of the Bmal1 mutation to the islet. Notably, the pancreas-specific Bmal1 knockout mice showed normal circadian activity, feeding rhythms and body weight and composition (Supplementary Fig. 8b-h) . Remarkably, however, we found that 2-4month-old PdxCre Bmal1 flx/flx mice displayed significantly elevated ad libitum glucose levels throughout the day (Fig. 4d) , as well as markedly impaired glucose tolerance and decreased insulin secretion (Fig. 4e, f, Supplementary Fig. 9c, d and Supplementary Table 3 ). It is important to note that these phenotypes develop in PdxCre Bmal1 flx/flx mice at a young age (2-4 months) compared to the global Clock D19/D19 mutant mice. Furthermore, the impaired glucose tolerance in the pancreas-specific Bmal1 mutant mice was much more pronounced than in either the global Clock D19/D19 or Bmal1 nullizygous mice, consistent with compensation occurring in the global mutant mice and emphasizing the primary role of the islet clock in maintaining euglycaemia. Finally, because the pancreas-specific Bmal1 mutant mice have normal activity and feeding rhythms, as well as normal body weight ( Supplementary Fig. 8 ), the metabolic phenotypes that develop must be due to disruption of the clock network within the islet, rather than to Figure 3 | Reduced islet size, proliferation and insulin release in 8-10month-old circadian mutant mice. a, Glucose-stimulated insulin release in isolated Clock D19/D19 islets compared to similar-sized wild-type islets (n 5 9-10 mice per genotype), normalized to per cent insulin content. b, Insulin secretion from Clock D19/D19 islets in response to secretagogues (n 5 6-14). Insulin release was calculated as in a, and Clock D19/D19 values are expressed as a percentage of wild type. c, Representative islet morphology in Clock D19/D19 and wild-type pancreata (body weight and pancreata weight were not different). d, Size of islets isolated from Clock D19/D19 and Bmal1 2/2 mice compared to wild type (n 5 6-9). e, Ki67 staining of islet proliferation (Clock D19/D19 and wild type, n 5 5-6). f, Glucose-stimulated insulin secretion in Bmal1 2/2 islets compared to wild type (n 5 5). g, Insulin secretion from Bmal1 2/2 islets in response to secretagogues (n 5 6-10). Five islets per mouse were analysed in triplicate for each test condition; data were analysed by Student's t-test. *P , 0.05; **P , 0.01; all values represent mean 6 s.e.m. secondary changes in activity or behaviour. Interestingly, our isolated islet studies in the pancreas-specific Bmal1 knockout mice revealed diminished insulin responsiveness to glucose, KCl, exendin 4, forskolin and 8-bromo-cAMP, indicating a block in exocytosis (Fig. 4g, h) , similar to that of Clock D19/D19 and Bmal1 mutant mice. Thus, ablation of the pancreatic clock is sufficient to render the islet refractory to glucose and insulin secretagogues, resulting in hyperglycaemia.
The recent availability of both global and tissue-specific genetic models of circadian disruption offers unique opportunities to define the role of circadian oscillators in physiology. For instance, our previous studies in Clock D19/D19 mutant mice showed that these mice are susceptible to obesity and certain features of metabolic syndrome including steatosis, adipose hypertrophy and hyperlipidaemia, due to primary defects within both hypothalamus (decreased anorexigenic peptidergic signalling) and also liver. Yet, Clock D19/D19 mice have sufficient b-cell reserves early in life to drive adiposity, although eventually their weight gain plateaus coincident with progressive b-cell failure. In contrast, ablation of the clock within liver results in hypoglycaemia 24, 25 , whereas clock function within liver is also tied to reduced cholesterol extrusion as bile, steatosis and hypertriglyceridaemia, all features of metabolic syndrome [26] [27] [28] . In summary, obesity in circadian mutants is separable from insulin resistance, and the same defects that cause changes in b-cell function can ameliorate insulin resistance in the liver, through mechanisms that require further investigation. Our findings in b-cell conditional knockout mice underscore the intimate integration of circadian and metabolic systems within multiple tissues and the complex effect of clock function in separate tissues on energy and metabolic homeostasis in the whole animal. In addition to orchestrating the daily cycles of glucose metabolism, the islet circadian transcription network also participates in the determination of islet cell mass, similar to previously reported effects of the clock on growth and regeneration of bone 29 and liver 30 . Clinical evidence further indicates that temporal defects in insulin secretion are early indicators of b-cell dysfunction. Therefore, consideration of the dynamics of clock function across temporally distinct phases of the day/night cycle, and within different tissues as the cycle progresses, may also explain obesity and metabolic pathologies that emerge in states of circadian disruption including shift work and night eating. 
